Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Prolonged Tpeak -Tend interval is a risk factor for sudden cardiac death in adults with congenital heart disease.

Vehmeijer JT, Koyak Z, Vink AS, Budts W, Harris L, Silversides CK, Oechslin EN, Zwinderman AH, Mulder BJM, de Groot JR.

Congenit Heart Dis. 2019 Nov;14(6):952-957. doi: 10.1111/chd.12847. Epub 2019 Oct 1.

2.

PREVENTION-ACHD: PRospEctiVE study on implaNTable cardioverter-defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease; Rationale and Design.

Vehmeijer JT, Koyak Z, Zwinderman AH, Harris L, Peinado R, Oechslin EN, Silversides CK, Bouma BJ, Budts W, van Gelder IC, Oliver JM, Mulder BJM, de Groot JR.

Neth Heart J. 2019 Oct;27(10):474-479. doi: 10.1007/s12471-019-1297-3.

3.

Prevention of Sudden Cardiac Death in Adults With Congenital Heart Disease: Do the Guidelines Fall Short?

Vehmeijer JT, Koyak Z, Budts W, Harris L, Silversides CK, Oechslin EN, Bouma BJ, Zwinderman AH, Mulder BJM, de Groot JR.

Circ Arrhythm Electrophysiol. 2017 Jul;10(7). pii: e005093. doi: 10.1161/CIRCEP.116.005093.

PMID:
28696220
4.

Sudden cardiac death in adults with congenital heart disease: does QRS-complex fragmentation discriminate in structurally abnormal hearts?

Vehmeijer JT, Koyak Z, Bokma JP, Budts W, Harris L, Mulder BJM, de Groot JR.

Europace. 2018 Jun 1;20(FI1):f122-f128. doi: 10.1093/europace/eux044.

PMID:
28402450
5.

Cardiac resynchronization therapy in adults with congenital heart disease.

Koyak Z, de Groot JR, Krimly A, Mackay TM, Bouma BJ, Silversides CK, Oechslin EN, Hoke U, van Erven L, Budts W, Van Gelder IC, Mulder BJM, Harris L.

Europace. 2018 Feb 1;20(2):315-322. doi: 10.1093/europace/euw386.

PMID:
28108550
6.

Sudden cardiac death in adult congenital heart disease: can the unpredictable be foreseen?

Koyak Z, de Groot JR, Bouma BJ, Zwinderman AH, Silversides CK, Oechslin EN, Budts W, Van Gelder IC, Mulder BJ, Harris L.

Europace. 2017 Mar 1;19(3):401-406. doi: 10.1093/europace/euw060.

PMID:
27247006
7.

Cardiac magnetic resonance markers of progressive RV dilation and dysfunction after tetralogy of Fallot repair.

Wald RM, Valente AM, Gauvreau K, Babu-Narayan SV, Assenza GE, Schreier J, Gatzoulis MA, Kilner PJ, Koyak Z, Mulder B, Powell AJ, Geva T.

Heart. 2015 Nov;101(21):1724-30. doi: 10.1136/heartjnl-2015-308014. Epub 2015 Aug 14.

PMID:
26276804
8.

Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort.

Valente AM, Gauvreau K, Assenza GE, Babu-Narayan SV, Schreier J, Gatzoulis MA, Groenink M, Inuzuka R, Kilner PJ, Koyak Z, Landzberg MJ, Mulder B, Powell AJ, Wald R, Geva T.

Heart. 2014 Feb;100(3):247-53. doi: 10.1136/heartjnl-2013-304958. Epub 2013 Oct 31.

9.

Postoperative arrhythmias in adults with congenital heart disease: incidence and risk factors.

Koyak Z, Achterbergh RC, de Groot JR, Berger F, Koolbergen DR, Bouma BJ, Lagrand WK, Hazekamp MG, Blom NA, Mulder BJ.

Int J Cardiol. 2013 Oct 30;169(2):139-44. doi: 10.1016/j.ijcard.2013.08.087. Epub 2013 Sep 8.

PMID:
24071387
10.

Efficacy of antiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias.

Koyak Z, Kroon B, de Groot JR, Wagenaar LJ, van Dijk AP, Mulder BA, Van Gelder IC, Post MC, Mulder BJ, Bouma BJ.

Am J Cardiol. 2013 Nov 1;112(9):1461-7. doi: 10.1016/j.amjcard.2013.07.029. Epub 2013 Aug 29.

PMID:
23993125
11.

Sudden cardiac death in adult congenital heart disease.

Koyak Z, Harris L, de Groot JR, Silversides CK, Oechslin EN, Bouma BJ, Budts W, Zwinderman AH, Van Gelder IC, Mulder BJ.

Circulation. 2012 Oct 16;126(16):1944-54. doi: 10.1161/CIRCULATIONAHA.112.104786. Epub 2012 Sep 18.

PMID:
22991410
12.

Rationale and design of an International Multicenter Registry of patients with repaired tetralogy of Fallot to define risk factors for late adverse outcomes: the INDICATOR cohort.

Valente AM, Gauvreau K, Assenza GE, Babu-Narayan SV, Evans SP, Gatzoulis M, Groenink M, Inuzuka R, Kilner PJ, Koyak Z, Landzberg MJ, Mulder B, Powell AJ, Wald R, Geva T.

Pediatr Cardiol. 2013 Jan;34(1):95-104. doi: 10.1007/s00246-012-0394-5. Epub 2012 Jun 5.

PMID:
22669402
13.

Symptomatic but not asymptomatic non-sustained ventricular tachycardia is associated with appropriate implantable cardioverter therapy in tetralogy of Fallot.

Koyak Z, de Groot JR, Bouma BJ, Van Gelder IC, Budts W, Zwinderman AH, Mulder BJ.

Int J Cardiol. 2013 Aug 20;167(4):1532-5. doi: 10.1016/j.ijcard.2012.04.103. Epub 2012 May 18.

PMID:
22608897
14.

Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?

Koyak Z, de Groot JR, Van Gelder IC, Bouma BJ, van Dessel PF, Budts W, van Erven L, van Dijk AP, Wilde AA, Pieper PG, Sieswerda GT, Mulder BJ.

Circ Arrhythm Electrophysiol. 2012 Feb;5(1):101-10. doi: 10.1161/CIRCEP.111.966754. Epub 2011 Nov 17.

PMID:
22095638
15.

Interventional and surgical treatment of cardiac arrhythmias in adults with congenital heart disease.

Koyak Z, de Groot JR, Mulder BJ.

Expert Rev Cardiovasc Ther. 2010 Dec;8(12):1753-66. doi: 10.1586/erc.10.152. Review.

PMID:
21108557

Supplemental Content

Support Center